Video Experimental Relacionado
Updated: Jan 23, 2026
04:46
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
2.2K
ROS-responsive multifunctional DCS-based micelle hydrogel for simultaneously inhibiting post-resection melanoma
Sha Liu1, Lina Wang2, Yupeng Wang3
1Hebei Key Laboratory of Inorganic Nanomaterials, College of Chemistry and Material Science, Hebei Normal University, Shijiazhuang 050024, P. R. China. liusha@hebtu.edu.cn.
Nanoscale
|January 22, 2026
Resumen
This study developed a novel micelle hydrogel (AB@MH) for melanoma treatment. The hydrogel promotes wound healing and suppresses tumor recurrence by releasing anti-cancer drugs in response to reactive oxygen species (ROS).
Área de la Ciencia:
- Ciencia de Biomateriales
- Terapia contra el Cáncer
- Cicatrización de Heridas
Sus antecedentes:
- El retraso en la cicatrización de heridas post-resección de melanoma puede provocar recurrencia del tumor.
- El manejo postoperatorio eficaz requiere actividad anticancerígena simultánea y promoción de la cicatrización de heridas.
Objetivo del estudio:
- Desarrollar un hidrogel de micelas multifuncional (AB@MH) para la terapia integrada post-resección del melanoma.
- Lograr la liberación controlada de fármacos, mejorar la eficacia antitumoral y acelerar la reparación de heridas.
Principales métodos:
- Fabricación de un hidrogel a base de quitosano modificado con dodecilo (DCS) cargado conjuntamente con apigenina y BMS-202 dentro de micelas nanoresponsivas a ROS.
- Utilización de enlaces de base de Schiff y enlaces de hidrógeno para la formación de hidrogel.
- Evaluación in vivo en un modelo de resección de melanoma.
Principales resultados:
- La formulación AB@MH demostró una liberación de fármacos inducida por ROS, minimizando la toxicidad sistémica.
- La apigenina mostró citotoxicidad selectiva contra células tumorales y bacterias, induciendo muerte celular inmunogénica (ICD).
- La terapia combinada con BMS-202 mejoró la eficacia antitumoral sin dañar las células normales.
- AB@MH suprimió significativamente la recurrencia del tumor y aceleró la cicatrización de heridas in vivo.
Conclusiones:
- El AB@MH desarrollado es un material multifuncional seguro y eficaz para el tratamiento postoperatorio del melanoma.
- Este enfoque integra con éxito la terapia antitumoral y la mejora de la cicatrización de heridas.
- El estudio destaca una estrategia prometedora para mejorar los resultados en la atención del cáncer post-resección.
Videos de Conceptos Relacionados
02:40The Eukaryotic Promoter Region
18.7K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
02:40The Eukaryotic Promoter Region
3.8K
3.8K
00:46Feedback Inhibition
56.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
00:51Base-Promoted α-Halogenation of Aldehydes and Ketones
4.1K
α-Halogenation of aldehydes and ketones is a reaction involving the substitution of α hydrogens with halogens in the presence of a base. The reaction begins with the abstraction of α hydrogen by the base to produce a nucleophilic enolate ion. This intermediate undergoes a subsequent nucleophilic substitution with the halogen to produce a monohalogenated carbonyl compound. If the starting substrate has more than one α hydrogen, it is difficult to stop the reaction...
4.1K
01:30Enzyme Inhibition
91.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
00:50Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K